Identification	O
of	O
the	O
TCL1	B-DNA
gene	I-DNA
involved	O
in	O
T-cell	B-cell_type
malignancies	O
.	O

The	O
TCL1	B-DNA
locus	I-DNA
on	O
chromosome	B-DNA
14q32.1	I-DNA
is	O
frequently	O
involved	O
in	O
chromosomal	O
translocations	O
and	O
inversions	O
with	O
one	O
of	O
the	O
T-cell	B-DNA
receptor	I-DNA
loci	I-DNA
in	O
human	O
T-cell	O
leukemias	O
and	O
lymphomas	O
.	O

The	O
chromosome	B-DNA
14	I-DNA
region	I-DNA
translocated	O
or	O
rearranged	O
involves	O
approximately	O
350	O
kb	O
of	O
DNA	O
at	O
chromosome	O
band	O
14q32.1	O
.	O

Within	O
this	O
region	O
we	O
have	O
identified	O
a	O
gene	O
coding	O
for	O
a	O
1.3-kb	B-RNA
transcript	I-RNA
,	O
expressed	O
only	O
in	O
restricted	O
subsets	O
of	O
cells	O
within	O
the	O
lymphoid	B-cell_type
lineage	I-cell_type
and	O
expressed	O
at	O
high	O
levels	O
in	O
leukemic	B-cell_type
cells	I-cell_type
carrying	O
a	O
t	O
(	O
14	O
;	O
14	O
)	O
(	O
q11	O
;	O
q32	O
)	O
chromosome	O
translocation	O
or	O
a	O
inv	O
(	O
14	O
)	O
(	O
q11	O
;	O
q32	O
)	O
chromosome	O
inversion	O
.	O

The	O
cognate	B-DNA
cDNA	I-DNA
sequence	I-DNA
reveals	O
an	O
open	B-DNA
reading	I-DNA
frame	I-DNA
of	O
342	O
nt	O
encoding	O
a	O
protein	B-protein
of	I-protein
14	I-protein
kDa	I-protein
.	O

The	O
TCL1	B-DNA
gene	I-DNA
sequence	O
,	O
which	O
,	O
to	O
our	O
knowledge	O
,	O
shows	O
no	O
sequence	O
homology	O
with	O
other	O
human	B-DNA
genes	I-DNA
,	O
is	O
preferentially	O
expressed	O
early	O
in	O
T-	B-cell_type
and	I-cell_type
B-lymphocyte	I-cell_type
differentiation	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

91	NULL
,	NULL
pp	NULL
.	NULL

12530-12534	NULL
,	NULL
December	NULL
1994	NULL
Medical	NULL
Sciences	NULL
Identification	NULL
of	NULL
the	NULL
TCL1I	NULL
gene	NULL
involved	NULL
in	NULL
T-cell	NULL
malignancies	NULL
(	NULL
chromosome	NULL
14q32.1/B-cell	NULL
differentiation	NULL
/lymphoid	NULL
malignancies	NULL
)	NULL
Laura	NULL
Virom10**	NULL
,	NULL
Maria	NULL
Grazia	NULL
Narpuccit	NULL
?	NULL

,	NULL
MasanarU	NULL
Isose	NULL
$	NULL
§	NULL
,	NULL
Linpa	NULL
G	NULL
.	NULL

BicLips	NULL
!	NULL

,	NULL
Max	NULL
D.	NULL
CooPpERT	NULL
,	NULL
CARLO	NULL
M.	NULL
CROCE*	NULL
,	NULL
AND	NULL
GIANDOMENICO	NULL
Russot	NULL
*Jefferson	NULL
Cancer	NULL
Institute	NULL
and	NULL
Jefferson	NULL
Cancer	NULL
Center	NULL
,	NULL
Jefferson	NULL
Medical	NULL
College	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19107	NULL
;	NULL
*Raggio-Italgene	NULL
,	NULL
SpA	NULL
,	NULL
Via	NULL
delle	NULL
Antille	NULL
29	NULL
,	NULL
Pomezia	NULL
00040	NULL
,	NULL
Italy	NULL
;	NULL
$	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
Laboratory	NULL
,	NULL
Chemical	NULL
and	NULL
Biochemical	NULL
Engineering	NULL
,	NULL
Faculty	NULL
of	NULL
Engineering	NULL
,	NULL
Toyama	NULL
University	NULL
,	NULL
Toyama	NULL
City	NULL
,	NULL
930	NULL
Japan	NULL
;	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Alabama	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
35294	NULL
Contributed	NULL
by	NULL
Max	NULL
D.	NULL
Cooper	NULL
,	NULL
September	NULL
21	NULL
,	NULL
1994	NULL
ABSTRACT	NULL
The	NULL
TCL1	NULL
locus	NULL
on	NULL
chromosome	NULL
14q32.1	NULL
is	NULL
frequently	NULL
involved	NULL
in	NULL
chromosomal	NULL
translocations	NULL
and	NULL
inversions	NULL
with	NULL
one	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
loci	NULL
in	NULL
human	NULL
T-cell	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
.	NULL

The	NULL
chromosome	NULL
14	NULL
region	NULL
trans-located	NULL
or	NULL
rearranged	NULL
involves	NULL
~350	NULL
kb	NULL
of	NULL
DNA	NULL
at	NULL
chromosome	NULL
band	NULL
14q32.1	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
gene	NULL
coding	NULL
for	NULL
a	NULL
1.3-kb	NULL
transcript	NULL
,	NULL
expressed	NULL
only	NULL
in	NULL
restricted	NULL
subsets	NULL
of	NULL
cells	NULL
within	NULL
the	NULL
lymphoid	NULL
lineage	NULL
and	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
leukemic	NULL
cells	NULL
carrying	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q432	NULL
)	NULL
chromosome	NULL
translocation	NULL
or	NULL
a	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
chromosome	NULL
in-version	NULL
.	NULL

The	NULL
cognate	NULL
cDNA	NULL
sequence	NULL
reveals	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
342	NULL
nt	NULL
encoding	NULL
a	NULL
protein	NULL
of	NULL
14	NULL
kDa	NULL
.	NULL

The	NULL
TCLI	NULL
gene	NULL
sequence	NULL
,	NULL
which	NULL
,	NULL
to	NULL
our	NULL
knowledge	NULL
,	NULL
shows	NULL
no	NULL
sequence	NULL
homology	NULL
with	NULL
other	NULL
human	NULL
genes	NULL
,	NULL
is	NULL
preferentially	NULL
expressed	NULL
early	NULL
in	NULL
T-	NULL
and	NULL
B-lymphocyte	NULL
differentiation	NULL
.	NULL

Nonrandom	NULL
chromosomal	NULL
translocations	NULL
are	NULL
characteristic	NULL
of	NULL
most	NULL
human	NULL
hematopoetic	NULL
malignancies	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
chromosomal	NULL
translocations	NULL
and	NULL
inversions	NULL
often	NULL
occur	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
mistakes	NULL
during	NULL
the	NULL
normal	NULL
process	NULL
of	NULL
recombination	NULL
of	NULL
the	NULL
genes	NULL
for	NULL
immunoglobulins	NULL
or	NULL
T-cell	NULL
receptors	NULL
(	NULL
TCRs	NULL
)	NULL
.	NULL

These	NULL
rearrangements	NULL
juxtapose	NULL
enhancer	NULL
elements	NULL
of	NULL
the	NULL
immunoglobulin	NULL
or	NULL
TCR	NULL
genes	NULL
to	NULL
oncogenes	NULL
whose	NULL
expression	NULL
is	NULL
then	NULL
deregulated	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
cases	NULL
,	NULL
the	NULL
rearrangements	NULL
observed	NULL
in	NULL
lymphoid	NULL
malignancies	NULL
occur	NULL
between	NULL
two	NULL
different	NULL
chromosomes	NULL
.	NULL

Rearrangements	NULL
of	NULL
the	NULL
TCLI	NULL
locus	NULL
at	NULL
chromosome	NULL
14q32.1	NULL
are	NULL
unique	NULL
,	NULL
in	NULL
that	NULL
the	NULL
other	NULL
locus	NULL
involved	NULL
in	NULL
these	NULL
rearrangements	NULL
,	NULL
namely	NULL
,	NULL
the	NULL
TCR	NULL
a/	NULL
8	NULL
locus	NULL
,	NULL
is	NULL
also	NULL
on	NULL
chromosome	NULL
14	NULL
at	NULL
subband	NULL
qll	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
the	NULL
rearrangements	NULL
observed	NULL
cytogenetically	NULL
are	NULL
either	NULL
chromosomal	NULL
inversions	NULL
,	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
,	NULL
involving	NULL
only	NULL
one	NULL
of	NULL
the	NULL
chromosomes	NULL
14	NULL
or	NULL
translocations	NULL
involving	NULL
both	NULL
chromosomes	NULL
14	NULL
,	NULL
such	NULL
as	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
or	NULL
,	NULL
more	NULL
rarely	NULL
,	NULL
the	NULL
t	NULL
(	NULL
7	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q35	NULL
;	NULL
q32	NULL
)	NULL
involving	NULL
the	NULL
TCRB	NULL
locus	NULL
at	NULL
7435	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
abnormalities	NULL
are	NULL
associated	NULL
with	NULL
postthymic	NULL
types	NULL
of	NULL
T-cell	NULL
leukemias	NULL
,	NULL
such	NULL
as	NULL
T-prolymphocytic	NULL
leukemia	NULL
(	NULL
T-PLL	NULL
)	NULL
(	NULL
5	NULL
)	NULL
and	NULL
acute	NULL
or	NULL
chronic	NULL
T-cell	NULL
leukemias	NULL
developing	NULL
in	NULL
patients	NULL
with	NULL
ataxia	NULL
te-langectasia	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Several	NULL
of	NULL
the	NULL
breakpoints	NULL
at	NULL
14q32.1	NULL
involved	NULL
in	NULL
these	NULL
translocations	NULL
have	NULL
been	NULL
cloned	NULL
and	NULL
char-acterized	NULL
,	NULL
but	NULL
the	NULL
putative	NULL
TCLI	NULL
oncogene	NULL
had	NULL
not	NULL
been	NULL
identified	NULL
(	NULL
6	NULL
,	NULL
8-10	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
cloned	NULL
the	NULL
entire	NULL
TCLI	NULL
locus	NULL
,	NULL
a	NULL
chromosomal	NULL
region	NULL
of	NULL
~350	NULL
kb	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
placement	NULL
of	NULL
translocation	NULL
breakpoints	NULL
on	NULL
the	NULL
long-range	NULL
genomic	NULL
map	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
such	NULL
a	NULL
large	NULL
region	NULL
suggests	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
putative	NULL
TCLI	NULL
gene	NULL
can	NULL
occur	NULL
from	NULL
a	NULL
distance	NULL
of	NULL
many	NULL
kilobases	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
for	NULL
the	NULL
BCL1I/CCND1	NULL
gene	NULL
in	NULL
mantle-cell	NULL
lymphoma	NULL
(	NULL
12-15	NULL
)	NULL
and	NULL
the	NULL
MYC	NULL
oncogene	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
and	NULL
in	NULL
acute	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

12530	NULL
T-cell	NULL
leukemia	NULL
(	NULL
18	NULL
)	NULL
.	NULL

It	NULL
also	NULL
became	NULL
evident	NULL
from	NULL
the	NULL
mapping	NULL
studies	NULL
that	NULL
the	NULL
breakpoints	NULL
of	NULL
the	NULL
different	NULL
rearrangements	NULL
segregate	NULL
in	NULL
two	NULL
clusters	NULL
;	NULL
inversions	NULL
on	NULL
the	NULL
centromeric	NULL
side	NULL
and	NULL
simple	NULL
balanced	NULL
translocations	NULL
on	NULL
the	NULL
telomeric	NULL
side	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
thus	NULL
postulated	NULL
that	NULL
if	NULL
the	NULL
target	NULL
gene	NULL
activated	NULL
by	NULL
these	NULL
different	NULL
types	NULL
of	NULL
chromosomal	NULL
rearrangements	NULL
is	NULL
the	NULL
same	NULL
,	NULL
the	NULL
gene	NULL
must	NULL
reside	NULL
between	NULL
the	NULL
two	NULL
clusters	NULL
of	NULL
breakpoints	NULL
in	NULL
a	NULL
region	NULL
of	NULL
~160	NULL
kb	NULL
.	NULL

We	NULL
have	NULL
used	NULL
two	NULL
approaches	NULL
to	NULL
search	NULL
for	NULL
the	NULL
elusive	NULL
TCL	NULL
]	NULL
gene	NULL
:	NULL
exon	NULL
trapping	NULL
and	NULL
Northern	NULL
blot	NULL
hybridization	NULL
with	NULL
unique	NULL
probes	NULL
derived	NULL
from	NULL
genomic	NULL
clones	NULL
adjacent	NULL
to	NULL
CG-rich	NULL
regions	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
!	NULL

and	NULL
its	NULL
preferential	NULL
expression	NULL
early	NULL
in	NULL
both	NULL
the	NULL
T-	NULL
and	NULL
B-lymphocyte	NULL
differentiation	NULL
pathways	NULL
.	NULL

METHODS	NULL
Isolation	NULL
of	NULL
Unique	NULL
Probes	NULL
.	NULL

DNA	NULL
of	NULL
P1	NULL
clones	NULL
7-4	NULL
and	NULL
20-21	NULL
were	NULL
doubly	NULL
digested	NULL
,	NULL
the	NULL
former	NULL
with	NULL
Cla	NULL
I	NULL
and	NULL
EcoRI	NULL
and	NULL
the	NULL
latter	NULL
with	NULL
Sal	NULL
I	NULL
and	NULL
EcoRI	NULL
or	NULL
with	NULL
Eag	NULL
I	NULL
and	NULL
HindIII	NULL
,	NULL
and	NULL
subcloned	NULL
in	NULL
pBSII	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

DNA	NULL
of	NULL
the	NULL
positive	NULL
sub-clones	NULL
was	NULL
prepared	NULL
by	NULL
standard	NULL
minipreparation	NULL
method	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Repeat-free	NULL
DNA	NULL
fragments	NULL
were	NULL
identified	NULL
by	NULL
Southern	NULL
blot	NULL
hybridization	NULL
with	NULL
human	NULL
cot-1	NULL
DNA	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Exon	NULL
Trapping	NULL
.	NULL

The	NULL
pES53	NULL
vector	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Ohta	NULL
(	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
)	NULL
;	NULL
it	NULL
is	NULL
a	NULL
reproduction	NULL
of	NULL
the	NULL
pMHC2	NULL
vector	NULL
(	NULL
21	NULL
)	NULL
.	NULL

It	NULL
contains	NULL
a	NULL
portion	NULL
of	NULL
p53	NULL
exon	NULL
10	NULL
,	NULL
intron	NULL
10	NULL
,	NULL
and	NULL
a	NULL
portion	NULL
of	NULL
exon	NULL
11	NULL
;	NULL
a	NULL
unique	NULL
Bagi	NULL
II	NULL
site	NULL
is	NULL
present	NULL
in	NULL
intron	NULL
10	NULL
for	NULL
cloning	NULL
.	NULL

DNA	NULL
of	NULL
P1	NULL
clones	NULL
7-4	NULL
and	NULL
20-21	NULL
(	NULL
each	NULL
at	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
partially	NULL
digested	NULL
with	NULL
Sau3A	NULL
.	NULL

The	NULL
digested	NULL
DNA	NULL
of	NULL
between	NULL
0.5	NULL
and	NULL
5	NULL
kb	NULL
was	NULL
isolated	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Bai	NULL
II	NULL
site	NULL
of	NULL
pE53	NULL
.	NULL

Cloned	NULL
DNA	NULL
,	NULL
5-10	NULL
ug	NULL
,	NULL
was	NULL
transfected	NULL
into	NULL
semiconfluent	NULL
COS-7	NULL
cells	NULL
by	NULL
using	NULL
Lipofectase	NULL
(	NULL
BRL	NULL
)	NULL
.	NULL

After	NULL
30	NULL
h	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
by	NULL
Buckler	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
.	NULL

Amplification	NULL
of	NULL
total	NULL
RNA	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
primers	NULL
and	NULL
procedures	NULL
described	NULL
by	NULL
Hamaguchi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
TCLI	NULL
cDNA	NULL
.	NULL

A	NULL
cDNA	NULL
library	NULL
was	NULL
constructed	NULL
with	NULL
a	NULL
commercial	NULL
kit	NULL
for	NULL
A	NULL
Zap	NULL
cDNA	NULL
synthesis	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
ligation	NULL
was	NULL
packaged	NULL
with	NULL
Gigapak	NULL
II	NULL
Gold	NULL
packaging	NULL
extract	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

cDNA	NULL
libraries	NULL
constructed	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
ALL1	NULL
and	NULL
697	NULL
were	NULL
kindly	NULL
donated	NULL
by	NULL
T.	NULL
Nakamura	NULL
and	NULL
A.	NULL
ar-Rushdi	NULL
,	NULL
respectively	NULL
(	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
)	NULL
.	NULL

The	NULL
libraries	NULL
were	NULL
plated	NULL
and	NULL
screened	NULL
with	NULL
standard	NULL
protocols	NULL
(	NULL
20	NULL
)	NULL
.	NULL
'	NULL

Abbreviations	NULL
:	NULL
TCR	NULL
,	NULL
T-cell	NULL
receptor	NULL
;	NULL
T-PLL	NULL
,	NULL
T-prolymphocytic	NULL
leukemia	NULL
;	NULL
PBL	NULL
,	NULL
peripheral	NULL
blood	NULL
leukemia	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglu-	NULL
tinin	NULL
;	NULL
ORF	NULL
,	NULL
open	NULL
reading	NULL
frame	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription	NULL
,	NULL
PCR	NULL
.	NULL

*L.V	NULL
.	NULL

and	NULL
M.G.N	NULL
.	NULL

have	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
publication	NULL
.	NULL

!	NULL

The	NULL
sequence	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
data	NULL
base	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

X82240	NULL
)	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Virgilio	NULL
et	NULL
al	NULL
.	NULL

Prokaryotic	NULL
Expression	NULL
.	NULL

p697	NULL
cDNA	NULL
was	NULL
digested	NULL
with	NULL
Nco	NULL
I	NULL
and	NULL
EcoRI	NULL
,	NULL
and	NULL
the	NULL
5	NULL
'	NULL
protruding	NULL
ends	NULL
were	NULL
filled-in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
purified	NULL
DNA	NULL
fragment	NULL
was	NULL
ligated	NULL
to	NULL
pQE30	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
previously	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
blunted	NULL
with	NULL
the	NULL
Klenow	NULL
polymerase	NULL
.	NULL

Positives	NULL
clones	NULL
were	NULL
selected	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
continuous	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORF	NULL
)	NULL
between	NULL
the	NULL
vector	NULL
ATG	NULL
and	NULL
the	NULL
cDNA	NULL
ATG	NULL
was	NULL
confirmed	NULL
by	NULL
sequence	NULL
analysis	NULL
.	NULL

Induction	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
cloned	NULL
sequences	NULL
and	NULL
purification	NULL
of	NULL
the	NULL
recombinant	NULL
peptide	NULL
were	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
Qiagen	NULL
.	NULL

In	NULL
Vitro	NULL
Translation	NULL
.	NULL

A	NULL
plasmid	NULL
,	NULL
pALL1	NULL
,	NULL
containing	NULL
full-length	NULL
TCLI	NULL
cDNA	NULL
was	NULL
linearized	NULL
by	NULL
digestion	NULL
with	NULL
Cia	NULL
I	NULL
and	NULL
transcribed	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
using	NULL
the	NULL
TNT	NULL
Coupled	NULL
Reticulocyte	NULL
Lysate	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

RT-PCR	NULL
.	NULL

First-strand	NULL
DNA	NULL
synthesis	NULL
was	NULL
performed	NULL
using	NULL
1	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
with	NULL
either	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
(	NULL
BRL	NULL
)	NULL
or	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
or	NULL
Superscript	NULL
(	NULL
BRL	NULL
)	NULL
reverse	NULL
transcriptase	NULL
and	NULL
respective	NULL
reaction	NULL
buffers	NULL
with	NULL
either	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
or	NULL
random	NULL
primers	NULL
;	NULL
10	NULL
%	NULL
of	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
subsequently	NULL
used	NULL
for	NULL
each	NULL
single	NULL
PCR	NULL
ampli-fication	NULL
.	NULL

Amplification	NULL
of	NULL
DNA	NULL
from	NULL
isolated	NULL
populations	NULL
of	NULL
bone	NULL
marrow	NULL
B	NULL
cells	NULL
,	NULL
T-cell	NULL
lines	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
,	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
-stimulated	NULL
PBL	NULL
s	NULL
,	NULL
and	NULL
thymus	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
primers	NULL
p9A	NULL
(	NULL
TGCTGCCAGATGACTGATGT	NULL
)	NULL
and	NULL
RevIll	NULL
(	NULL
CAAATG-GAATCCTCCTTGGC	NULL
)	NULL
,	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
denaturing	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
annealing	NULL
1	NULL
min	NULL
at	NULL
58°C	NULL
,	NULL
and	NULL
elongation	NULL
1	NULL
min	NULL
at	NULL
72°C	NULL
for	NULL
a	NULL
total	NULL
30	NULL
cycles	NULL
.	NULL

Amplification	NULL
of	NULL
DNA	NULL
from	NULL
patients	NULL
with	NULL
T-PLL	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
TCLLI	NULL
primers	NULL
Daudi	NULL
unil	NULL
(	NULL
AGGCCTATGACCCCCACC	NULL
)	NULL
and	NULL
Daudi	NULL
rev2	NULL
(	NULL
CATTCCTCCCAGACCCCA	NULL
)	NULL
,	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
above	NULL
,	NULL
except	NULL
for	NULL
the	NULL
annealing	NULL
temperature	NULL
,	NULL
which	NULL
was	NULL
60°C	NULL
.	NULL

The	NULL
PCR	NULL
internal	NULL
standard	NULL
used	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
B-actin	NULL
gene	NULL
were	NULL
used	NULL
:	NULL
A1	NULL
(	NULL
TCATCACCAT-TGGCAATGAG	NULL
)	NULL
and	NULL
A2	NULL
(	NULL
CAGTGTGTTGGCGTA-CAGGT	NULL
)	NULL
.	NULL

These	NULL
primers	NULL
were	NULL
used	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
the	NULL
TCLI	NULL
primers	NULL
.	NULL

Isolation	NULL
of	NULL
CD34*CD19+*	NULL
Cells	NULL
by	NULL
Immunofluorescence	NULL
Cell	NULL
Sorting	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
18-	NULL
to	NULL
22-week	NULL
aborted	NULL
fetuses	NULL
in	NULL
accordance	NULL
with	NULL
policies	NULL
established	NULL
A	NULL
1	NULL
{	NULL
14	NULL
;	NULL
14	NULL
)	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
l	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
|	NULL
m	NULL
EZ	NULL
c8	NULL
Ds	NULL
§	NULL
s	NULL
-	NULL
x	NULL
ﬁg	NULL
:	NULL
O	NULL
a	NULL
Pro—	NULL
<	NULL
5	NULL
l	NULL
me3	NULL
Em	NULL
m	NULL
IQ	NULL
‘	NULL
;	NULL
J	NULL
BBF	NULL
&	NULL
centromere	NULL
20-21	NULL
100	NULL
bp	NULL
exé	NULL
ex3	NULL
ee	NULL
ATG	NULL
TGA	NULL
gUTR	NULL
s	NULL
1	NULL
cona	NULL
[	NULL
_|	NULL
an	NULL
100	NULL
bp	NULL
I-14	NULL
|-	NULL
=	NULL
R1	NULL
H1	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
-	NULL
12531	NULL
by	NULL
an	NULL
institutional	NULL
review	NULL
board	NULL
.	NULL

Mononuclear	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
then	NULL
isolated	NULL
by	NULL
centrifugation	NULL
of	NULL
cell	NULL
suspensions	NULL
over	NULL
a	NULL
Ficoll/Hypaque	NULL
gradient	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
monoclonal	NULL
antibodies	NULL
used	NULL
for	NULL
cell	NULL
surface	NULL
analysis	NULL
included	NULL
anti-human	NULL
Leu-12	NULL
,	NULL
which	NULL
recognizes	NULL
the	NULL
pan-B	NULL
cell	NULL
antigen	NULL
CD19	NULL
,	NULL
anti-human	NULL
HPCA-2	NULL
,	NULL
which	NULL
detects	NULL
the	NULL
early	NULL
stem	NULL
cell	NULL
marker	NULL
CD34	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
and	NULL
goat	NULL
anti-human	NULL
IgM	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
)	NULL
.	NULL

For	NULL
two-color	NULL
surface	NULL
analysis	NULL
for	NULL
cell	NULL
sorting	NULL
,	NULL
viable	NULL
FBM	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
anti-CD34	NULL
antibodies	NULL
or	NULL
goat	NULL
anti-human	NULL
IgM	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
HIFCS	NULL
,	NULL
and	NULL
counterstained	NULL
with	NULL
phycoerythrin-conjugated	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
CD19	NULL
.	NULL

Subpopulations	NULL
of	NULL
lymphocytes	NULL
were	NULL
sorted	NULL
according	NULL
to	NULL
immunofluorescence	NULL
and	NULL
light	NULL
scatter	NULL
characteristics	NULL
with	NULL
a	NULL
FACStar	NULL
instrument	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

The	NULL
lymphocyte	NULL
subpopulations	NULL
collected	NULL
were	NULL
CD34*CD19~	NULL
,	NULL
CD34*CD19+	NULL
,	NULL
CD19®m~	NULL
,	NULL
CD19	NULL
``	NULL
'	NULL
p-	NULL
,	NULL
CD19+w	NULL
'	NULL
``	NULL
*	NULL
,	NULL
and	NULL
CD19+	NULL
p	NULL
``	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
and	NULL
counted	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
Tri-Reagent	NULL
(	NULL
Molecular	NULL
Research	NULL
Cen-ter	NULL
)	NULL
.	NULL

Cell	NULL
Lines	NULL
and	NULL
Lymphocytes	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

SupT11	NULL
is	NULL
a	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
patient	NULL
NL	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Peripheral	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
whole	NULL
blood	NULL
by	NULL
centrifugation	NULL
on	NULL
a	NULL
Ficoll/Hypaque	NULL
gradient	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
1-h	NULL
adherence	NULL
to	NULL
Petri	NULL
dishes	NULL
to	NULL
remove	NULL
the	NULL
monocytes	NULL
.	NULL

Stimulation	NULL
with	NULL
PHA	NULL
was	NULL
carried	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.1	NULL
%	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Patients	NULL
62	NULL
and	NULL
312	NULL
presented	NULL
with	NULL
T-PLL	NULL
involving	NULL
an	NULL
inversion	NULL
of	NULL
chromosome	NULL
14	NULL
,	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
.	NULL

RESULTS	NULL
Cloning	NULL
of	NULL
the	NULL
TCL1I	NULL
Gene	NULL
.	NULL

The	NULL
search	NULL
for	NULL
the	NULL
TCLI	NULL
gene	NULL
was	NULL
focused	NULL
on	NULL
the	NULL
region	NULL
included	NULL
between	NULL
the	NULL
two	NULL
sets	NULL
of	NULL
breakpoints	NULL
of	NULL
=~160	NULL
kb	NULL
and	NULL
encompassed	NULL
by	NULL
the	NULL
P1	NULL
clones	NULL
7-4	NULL
and	NULL
20-21	NULL
(	NULL
11	NULL
)	NULL
,	NULL
as	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

To	NULL
identify	NULL
transcribed	NULL
sequences	NULL
,	NULL
the	NULL
area	NULL
surrounding	NULL
restriction	NULL
sites	NULL
of	NULL
rare	NULL
cutter	NULL
enzymes	NULL
in	NULL
these	NULL
two	NULL
P1	NULL
clones	NULL
was	NULL
subcloned	NULL
and	NULL
unique	NULL
probes	NULL
were	NULL
isolated	NULL
.	NULL

The	NULL
recognition	NULL
sites	NULL
of	NULL
rare	NULL
cutting	NULL
enzymes	NULL
(	NULL
such	NULL
as	NULL
Miu	NULL
I	NULL
,	NULL
Nru	NULL
I	NULL
,	NULL
and	NULL
Not	NULL
1	NULL
)	NULL
,	NULL
rich	NULL
in	NULL
CG	NULL
114	NULL
;	NULL
14	NULL
)	NULL
1	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
17	NULL
;	NULL
14	NULL
)	NULL
l	NULL
l	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Genomic	NULL
and	NULL
cDNA	NULL
KKC	NULL
organization	NULL
of	NULL
the	NULL
TCL	NULL
I	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Genomic	NULL
organization	NULL
of	NULL
the	NULL
TCL	NULL
]	NULL
r	NULL
locus	NULL
on	NULL
chromosome	NULL
14q32.1	NULL
.	NULL

Vertical	NULL
bars	NULL
refers	NULL
to	NULL
cloned	NULL
breakpoints	NULL
in	NULL
the	NULL
literature	NULL
[	NULL
see	NULL
Virgilio	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
for	NULL
references	NULL
]	NULL
.	NULL

Restriction	NULL
sites	NULL
are	NULL
given	NULL
for	NULL
BssHII	NULL
(	NULL
B	NULL
)	NULL
,	NULL
Cla	NULL
I	NULL
(	NULL
C	NULL
)	NULL
,	NULL
Eag	NULL
I	NULL
(	NULL
E	NULL
)	NULL
,	NULL
Sfi	NULL
I	NULL
(	NULL
F	NULL
)	NULL
,	NULL
Ksp	NULL
I	NULL
(	NULL
K	NULL
)	NULL
,	NULL
Miu	NULL
l	NULL
(	NULL
M	NULL
)	NULL
,	NULL
Not	NULL
I	NULL
(	NULL
N	NULL
)	NULL
,	NULL
Nru	NULL
I	NULL
(	NULL
R	NULL
)	NULL
,	NULL
EcoRI	NULL
(	NULL
R1	NULL
)	NULL
,	NULL
Sal	NULL
I	NULL
(	NULL
S	NULL
)	NULL
,	NULL
HindIII	NULL
(	NULL
H	NULL
)	NULL
,	NULL
and	NULL
BamHI	NULL
(	NULL
H1	NULL
)	NULL
.	NULL

P1	NULL
clones	NULL
7-4	NULL
and	NULL
20-21	NULL
,	NULL
covering	NULL
the	NULL
140-kb	NULL
region	NULL
between	NULL
the	NULL
two	NULL
``	NULL
~	NULL
.	NULL

,	NULL
clusters	NULL
of	NULL
cloned	NULL
breakpoints	NULL
,	NULL
are	NULL
shown	NULL
by	NULL
horizontal	NULL
bars	NULL
.	NULL

Solid	NULL
boxes	NULL
represent	NULL
probes	NULL
used	NULL
for	NULL
RNA	NULL
screening	NULL
.	NULL

A	NULL
Sal	NULL
I-HindIH	NULL
genomic	NULL
fragment	NULL
with	NULL
the	NULL
organization	NULL
of	NULL
the	NULL
four	NULL
exons	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
is	NULL
enlarged	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TCLI	NULL
cDNA	NULL
structure	NULL
.	NULL

An	NULL
open	NULL
box	NULL
represents	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
;	NULL
a	NULL
solid	NULL
box	NULL
represents	NULL
encoding	NULL
sequence	NULL
,	NULL
and	NULL
a	NULL
hatched	NULL
box	NULL
represents	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
.	NULL

telomere	NULL
&	NULL
ALL320	NULL
«	NULL
--	NULL
f	NULL
*	NULL
--	NULL
z	NULL
:	NULL
d	NULL
ex1	NULL
12532	NULL
-	NULL
Medical	NULL
Sciences	NULL
:	NULL
Virgilio	NULL
et	NULL
al	NULL
.	NULL

content	NULL
,	NULL
may	NULL
indicate	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
CpG	NULL
island	NULL
;	NULL
such	NULL
CpG	NULL
islands	NULL
are	NULL
often	NULL
found	NULL
in	NULL
the	NULL
proximity	NULL
of	NULL
transcribed	NULL
genes	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Four	NULL
probes	NULL
were	NULL
generated	NULL
in	NULL
this	NULL
way	NULL
,	NULL
7-4CE	NULL
,	NULL
20-78E	NULL
,	NULL
20-7HE	NULL
,	NULL
and	NULL
9-1KK	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
Northern	NULL
blots	NULL
containing	NULL
RNAs	NULL
from	NULL
lymphoid	NULL
and	NULL
myelogenous	NULL
cell	NULL
lines	NULL
.	NULL

Only	NULL
the	NULL
probe	NULL
20-7HE	NULL
,	NULL
derived	NULL
from	NULL
sequences	NULL
adjacent	NULL
to	NULL
a	NULL
Not	NULL
I	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
detected	NULL
a	NULL
transcript	NULL
in	NULL
the	NULL
RNA	NULL
from	NULL
hematopoetic	NULL
cell	NULL
lines	NULL
.	NULL

This	NULL
transcript	NULL
~1.3	NULL
kb	NULL
was	NULL
clearly	NULL
visible	NULL
in	NULL
the	NULL
pre-B	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
ALL380	NULL
and	NULL
in	NULL
the	NULL
endemic	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
Daudi	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Three	NULL
cDNA	NULL
libraries	NULL
,	NULL
constructed	NULL
from	NULL
RNA	NULL
from	NULL
a	NULL
endemic	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
Daudi	NULL
)	NULL
and	NULL
two	NULL
pre-B-cell	NULL
lines	NULL
(	NULL
697	NULL
and	NULL
ALL1	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
1.3-kb	NULL
transcript	NULL
,	NULL
were	NULL
screened	NULL
with	NULL
the	NULL
20-7HE	NULL
probe	NULL
,	NULL
and	NULL
positive	NULL
clones	NULL
were	NULL
obtained	NULL
from	NULL
each	NULL
library	NULL
.	NULL

These	NULL
clones	NULL
were	NULL
designated	NULL
pAlDaudi	NULL
,	NULL
pAIl.5	NULL
,	NULL
and	NULL
p697	NULL
.	NULL

In	NULL
a	NULL
parallel	NULL
effort	NULL
to	NULL
identify	NULL
transcripts	NULL
,	NULL
the	NULL
P1	NULL
clones	NULL
20-21	NULL
and	NULL
7-4	NULL
were	NULL
partially	NULL
digested	NULL
with	NULL
Sau3A	NULL
and	NULL
cloned	NULL
into	NULL
an	NULL
exon-trapping	NULL
vector	NULL
containing	NULL
exon	NULL
10	NULL
,	NULL
intron	NULL
10	NULL
,	NULL
and	NULL
exon	NULL
11	NULL
of	NULL
the	NULL
p53	NULL
gene	NULL
.	NULL

Several	NULL
putative	NULL
exons	NULL
were	NULL
isolated	NULL
,	NULL
but	NULL
the	NULL
majority	NULL
were	NULL
due	NULL
to	NULL
aberrant	NULL
splicing	NULL
at	NULL
cryptic	NULL
splicing	NULL
sites	NULL
.	NULL

Some	NULL
trapped	NULL
DNA	NULL
fragments	NULL
contained	NULL
Alu	NULL
repeat	NULL
sequences	NULL
and	NULL
one	NULL
had	NULL
high	NULL
homology	NULL
to	NULL
transposon-like	NULL
sequences	NULL
.	NULL

However	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
one	NULL
of	NULL
the	NULL
trapped	NULL
fragments	NULL
matched	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
cDNA	NULL
isolated	NULL
from	NULL
the	NULL
697	NULL
and	NULL
ALL1	NULL
libraries	NULL
and	NULL
was	NULL
later	NULL
found	NULL
to	NULL
correspond	NULL
to	NULL
exon	NULL
3	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Sequence	NULL
Analysis	NULL
of	NULL
cDNA	NULL
Clones	NULL
.	NULL

All	NULL
three	NULL
cDNA	NULL
clones	NULL
were	NULL
entirely	NULL
sequenced	NULL
and	NULL
the	NULL
complete	NULL
sequence	NULL
of	NULL
pAIl.5	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Upon	NULL
sequence	NULL
comparison	NULL
,	NULL
pAlIl.5	NULL
and	NULL
p697	NULL
cDNAs	NULL
were	NULL
found	NULL
to	NULL
be	NULL
identical	NULL
,	NULL
except	NULL
for	NULL
a	NULL
base-pair	NULL
substitution	NULL
at	NULL
position	NULL
404	NULL
where	NULL
a	NULL
cytidine	NULL
in	NULL
pAIl.5	NULL
is	NULL
a	NULL
thymidine	NULL
in	NULL
p697	NULL
cDNA	NULL
.	NULL

pA1lDaudi	NULL
is	NULL
incomplete	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
,	NULL
missing	NULL
the	NULL
first	NULL
88	NULL
nt	NULL
,	NULL
and	NULL
additionally	NULL
showed	NULL
two	NULL
small	NULL
internal	NULL
deletions	NULL
:	NULL
the	NULL
pentamer	NULL
ATGGT	NULL
at	NULL
position	NULL
394	NULL
and	NULL
the	NULL
octamer	NULL
CTGCCCTT	NULL
at	NULL
position	NULL
707	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

All	NULL
three	NULL
clones	NULL
of	NULL
cDNA	NULL
had	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
of	NULL
slightly	NULL
different	NULL
length	NULL
;	NULL
pAIl.5	NULL
contains	NULL
the	NULL
longest	NULL
one	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
consensus	NULL
polyadenylylation	NULL
signal	NULL
at	NULL
position	NULL
1293	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
isolated	NULL
cDNAs	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
long	NULL
ORFs	NULL
.	NULL

Frame	NULL
1	NULL
contains	NULL
an	NULL
ORF	NULL
of	NULL
342	NULL
nt	NULL
with	NULL
a	NULL
starting	NULL
ATG	NULL
codon	NULL
at	NULL
position	NULL
46	NULL
,	NULL
located	NULL
within	NULL
a	NULL
perfect	NULL
Kozak	NULL
consensus	NULL
sequence	NULL
,	NULL
and	NULL
with	NULL
a	NULL
stop	NULL
codon	NULL
at	NULL
position	NULL
388	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
ORF	NULL
potentially	NULL
encodes	NULL
for	NULL
a	NULL
protein	NULL
of	NULL
114	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
mass	NULL
of	NULL
13.5	NULL
kDa	NULL
.	NULL

Frame	NULL
2	NULL
contains	NULL
an	NULL
ORF	NULL
with	NULL
a	NULL
starting	NULL
ATG	NULL
codon	NULL
at	NULL
position	NULL
383	NULL
and	NULL
a	NULL
stop	NULL
codon	NULL
at	NULL
position	NULL
773	NULL
,	NULL
to	NULL
give	NULL
a	NULL
putative	NULL
protein	NULL
of	NULL
14.5	NULL
kDa	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
this	NULL
second	NULL
ORF	NULL
,	NULL
a	NULL
deletion	NULL
in	NULL
two	NULL
of	NULL
the	NULL
three	NULL
independently	NULL
isolated	NULL
cDNA	NULL
clones	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
this	NULL
ORF	NULL
on	NULL
only	NULL
the	NULL
last	NULL
exon	NULL
led	NULL
us	NULL
to	NULL
believe	NULL
that	NULL
the	NULL
second	NULL
ORF	NULL
is	NULL
not	NULL
translated	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
ORF	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
encode	NULL
a	NULL
protein	NULL
,	NULL
the	NULL
entire	NULL
cDNA	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
prokaryotic	NULL
expression	NULL
vector	NULL
pQE30	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
shows	NULL
the	NULL
specific	NULL
induction	NULL
of	NULL
a	NULL
14-kDa	NULL
protein	NULL
and	NULL
the	NULL
protein	NULL
after	NULL
purifica-tion	NULL
.	NULL

These	NULL
results	NULL
were	NULL
also	NULL
confirmed	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
genomic	NULL
structure	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
with	NULL
probe	NULL
20-7HE	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
11	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
the	NULL
following	NULL
cell	NULL
lines	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
HeLa	NULL
;	NULL
2	NULL
,	NULL
Daudi	NULL
;	NULL
3	NULL
,	NULL
K562	NULL
;	NULL
4	NULL
,	NULL
AII380	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
1	NULL
CT	NULL
TCTGGCTCcTTGCTIcT	NULL
eecec	NULL
GCCATOGCCGAGTGCCCé	NULL
Mo	NULL
A	NULL
E	NULL
CoP	NULL
61	NULL
ACACTCGGGGAGGCAGTCACCGACCACCCGGACCGCCTGTGGGCCTGGGAGAAGTTCGTG	NULL
T	NULL
L	NULL
G	NULL
B	NULL
A	NULL
V	NULL
T	NULL
D	NULL
H	NULL
P	NULL
D	NULL
ROL	NULL
W	NULL
A	NULL
W	NULL
E	NULL
K	NULL
F	NULL
v	NULL
121	NULL
TATTTGGACGAGAAGCAGCACGCCTGGCTGCCCTTAACCATCGAGATAAAGGATAGGTTA	NULL
¥	NULL
L	NULL
D	NULL
B	NULL
K	NULL
Q	NULL
H	NULL
A	NULL
W	NULL
L	NULL
P	NULL
L	NULL
T	NULL
I	NULL
E	NULL
I	NULL
K	NULL
D	NULL
ROL	NULL
181	NULL
CAGTTACGGGTGCTCTTGCGTCGGGAAGACGTCGTCCTGGSGGAGGCCTATGACCCCCACC	NULL
Q	NULL
LOR	NULL
V	NULL
L	NULL
L	NULL
ROR	NULL
E	NULL
D	NULL
Vv	NULL
v	NULL
L	NULL
G	NULL
R	NULL
P	NULL
M	NULL
T	NULL
POT	NULL
241	NULL
CAGATAGGCCCAAGCCTGCTGCCTATCATGTGGCAGCTCTACCCTGATGGACGATACCGA	NULL
Q	NULL
I	NULL
G	NULL
P	NULL
§	NULL
L	NULL
L	NULL
P	NULL
I	NULL
M	NULL
W	NULL
Q	NULL
L	NULL
¥	NULL
P	NULL
D	NULL
G	NULL
R	NULL
OY	NULL
R	NULL
301	NULL
TCCTCAGACTCCAGTTTCTGGCGCTTAGTGTACCACATCAAGATTGACGGCGTGGAGGAC	NULL
8	NULL
8	NULL
D	NULL
s	NULL
8	NULL
F	NULL
w	NULL
R	NULL
L	NULL
v	NULL
%	NULL
H	NULL
I	NULL
K	NULL
I	NULL
D	NULL
G	NULL
v	NULL
E	NULL
b	NULL
ATGCTTCTCGAGCTGCTGCCAGATGACTGATGTATGGTCTTGGCAGCACCTGTCTCCTTT	NULL
MOL	NULL
L	NULL
B	NULL
L	NULL
L	NULL
P	NULL
D	NULL
D	NULL
*	NULL
ll4	NULL
421	NULL
CACCCCAGGGCCTGAGCCTGGCCAGCCTACAATGGGGATGTTGTGTTTCTGTICACCTTC	NULL
481	NULL
.	NULL

GTTTACTATGCCTGTGTCTTCTCCACCACGCTGGGGTCTGGGAGGAATGGACAGACAGAG	NULL
541	NULL
.	NULL

GATGAGCTCTACCCAGGGCCTGCAGGACCTGCCTGTAGCCCACTCTGCTCGCCTTAGCAC	NULL
CCAGCTATAC	NULL
361	NULL
601	NULL
TAC	NULL
Tec	NULL
TCCATTTGGCAGAGCTTCTTCC	NULL
661	NULL
CTGTGCCTCGGCTTTICTCcaG	NULL
721	NULL
CCTCACAGCACTAGTATTTCATGTTGCACACCCACTCAGCTCCGTGAACTTGTGAGAACA	NULL
'TCTTTCTGTCCCrICcrGrc	NULL
781	NULL
CAGCCGATTCACCTGA	NULL
TC	NULL
AACC	NULL
TCA	NULL
841	NULL
CGCCTGCATGTAAACACGCCTGCAAACGCTGCCTGCCGGTAAACACGCCTGCAAACGCTG	NULL
sor	NULL
-	NULL
coreect	NULL
A	NULL
rect	NULL
A	NULL
rccac	NULL
AC	NULL
as	NULL
961	NULL
GAAAGGCCTGAAAGGAGCCCTTATCTGTGCTCAGGACTCAGAAGCCTCTGGGTCAGTGGT	NULL
1021	NULL
ccac	NULL
AG	NULL
corcagaa	NULL
1081	NULL
-	NULL
CCCTTGGCTTGCCCACGTGGAAAAGGGATAGAGGTTGGGTTTCCCCCCTTTATAGATGGT	NULL
1141	NULL
-	NULL
CACGCACCTGGGTGTTACAAAGTTGTATGTGGCATGAATACTTTTTGTAATGATIGATTA	NULL
1201	NULL
-	NULL
AATGCAAGATAGTTTATCTAACTTCGTGCGCAMNTCAGCTTCTATCCTTGACTTAGATICT	NULL
1261	NULL
|	NULL
GGTGGAGAGAMGTGAGAATAGGCAGCCCCCAAATAAAAAATATTCATGGAAAAAAAAAAA	NULL
1321	NULL
AMMA	NULL
1324	NULL
B	NULL
1	NULL
GTCGACTGTGAGTTCCCAGCAGAGGCCCAGAGTCCCGGTCCGGCAGCCGAGGGAAGCGGG	NULL
61	NULL
GGGGTCTTCCAGAAGAAGAAAGGGCCAAGGTCACCCCGGTGCCTCTCCAGCAGCAGCAGA	NULL
121	NULL
-	NULL
[	NULL
Géec	NULL
@	NULL
ebeere	NULL
recrec	NULL
recececer	NULL
Acccocececcase	NULL
101	NULL
rec	NULL
TrGccaccorr	NULL
AGTcaGec	NULL
orrac	NULL
241	NULL
301	NULL
_	NULL
GCCTeCGCGeGaccercacmreccaccarcaccoccachaabecceccedarcerecerr	NULL
361.	NULL
.	NULL

AceECCceccochacercemrerceceaccceccer	NULL
(	NULL
Ecceccecaacaccercerfccel	NULL
)	NULL
421	NULL
.	NULL

[	NULL
CCCecqsrrreereccosccocarecreccCeeATA¥FAAAGGGTCGGCCCCACATCccas	NULL
481	NULL
...	NULL
ccaccaccenscoscerreacaceerereecrerreorrerracecesccceaceacece	NULL
se1	NULL
_	NULL
amgscceacrecccaacacr	NULL
560	NULL
Fig	NULL
.	NULL

3.	NULL
cDNA	NULL
sequence	NULL
and	NULL
5	NULL
genomic	NULL
sequence	NULL
of	NULL
TCLI	NULL
.	NULL

(	NULL
4	NULL
)	NULL
cDNA	NULL
sequence	NULL
of	NULL
TCLI	NULL
.	NULL

The	NULL
initiation	NULL
codon	NULL
ATG	NULL
is	NULL
shown	NULL
in	NULL
boldface	NULL
type	NULL
,	NULL
and	NULL
the	NULL
polyadenylylation	NULL
signal	NULL
is	NULL
underlined	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Genomic	NULL
sequence	NULL
5	NULL
'	NULL
to	NULL
the	NULL
cDNA	NULL
.	NULL

SP1	NULL
binding	NULL
sites	NULL
are	NULL
boxed	NULL
,	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
the	NULL
start	NULL
codon	NULL
are	NULL
in	NULL
boldface	NULL
type	NULL
,	NULL
and	NULL
the	NULL
cDNA	NULL
sequences	NULL
are	NULL
in	NULL
italic	NULL
type	NULL
.	NULL

a	NULL
Sal	NULL
I-HindlII	NULL
fragment	NULL
,	NULL
containing	NULL
the	NULL
entire	NULL
cDNA	NULL
,	NULL
was	NULL
subcloned	NULL
and	NULL
sequenced	NULL
.	NULL

The	NULL
map	NULL
and	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
gene	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
:	NULL
the	NULL
gene	NULL
is	NULL
composed	NULL
of	NULL
four	NULL
small	NULL
exons	NULL
with	NULL
a	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
~800	NULL
nt	NULL
.	NULL

The	NULL
sequence	NULL
immediately	NULL
5	NULL
'	NULL
to	NULL
the	NULL
cDNA	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
five	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
SP1	NULL
transcription	NULL
factor	NULL
and	NULL
a	NULL
TATA	NULL
box	NULL
at	NULL
position	NULL
-41	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
;	NULL
these	NULL
data	NULL
confirm	NULL
that	NULL
we	NULL
have	NULL
isolated	NULL
the	NULL
complete	NULL
cDNA	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
TCLI	NULL
Gene	NULL
in	NULL
T-Cell	NULL
Leukemia	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
isolated	NULL
gene	NULL
is	NULL
deregulated	NULL
in	NULL
cells	NULL
with	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
translocation	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
a	NULL
Northern	NULL
blot	NULL
analysis	NULL
comparing	NULL
the	NULL
amount	NULL
of	NULL
TCLL	NULL
transcript	NULL
present	NULL
in	NULL
resting	NULL
PBL	NULL
s	NULL
,	NULL
PHA-activated	NULL
PBL	NULL
s	NULL
,	NULL
SupT11	NULL
cells	NULL
[	NULL
a	NULL
cell	NULL
line	NULL
established	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
T-lymphocytic	NULL
leukemia	NULL
with	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
chromosomal	NULL
translocation	NULL
(	NULL
10	NULL
,	NULL
25	NULL
)	NULL
]	NULL
,	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
T-cell	NULL
leukemias	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

1	NULL
2	NULL
3	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Prokaryotic	NULL
expression	NULL
of	NULL
the	NULL
TCLI	NULL
gene	NULL
product	NULL
.	NULL

SDS/PAGE	NULL
of	NULL
bacterial	NULL
lysates	NULL
with	NULL
pQEtcl-1	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
unin-duced	NULL
;	NULL
2	NULL
,	NULL
induced	NULL
;	NULL
3	NULL
,	NULL
purified	NULL
.	NULL

14	NULL
kDa	NULL
--	NULL
Medical	NULL
Sciences	NULL
:	NULL
Virgilio	NULL
et	NULL
al	NULL
.	NULL

We	NULL
detected	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
SupT11	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

No	NULL
expression	NULL
was	NULL
detectable	NULL
in	NULL
several	NULL
other	NULL
tumor-derived	NULL
T-cell	NULL
lines	NULL
lacking	NULL
the	NULL
TCLJ	NULL
translocation	NULL
,	NULL
such	NULL
as	NULL
MOLT-4	NULL
,	NULL
HUT	NULL
78	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
SupT1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
also	NULL
confirmed	NULL
by	NULL
the	NULL
sensitive	NULL
assay	NULL
of	NULL
RT-PCR	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
.	NULL

Of	NULL
interest	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
SupT1	NULL
cells	NULL
carry	NULL
an	NULL
inverted	NULL
chromosome	NULL
14	NULL
,	NULL
inv14	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
TCRa	NULL
locus	NULL
is	NULL
not	NULL
juxtaposed	NULL
to	NULL
the	NULL
TCL1	NULL
but	NULL
is	NULL
positioned	NULL
in	NULL
front	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
locus	NULL
at	NULL
14q32.3	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Thus	NULL
an	NULL
inversion	NULL
of	NULL
chromosome	NULL
14	NULL
that	NULL
does	NULL
not	NULL
involve	NULL
the	NULL
TCL1	NULL
locus	NULL
is	NULL
unable	NULL
to	NULL
deregulate	NULL
the	NULL
TCLI	NULL
gene	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
semiquantitative	NULL
RT-PCR	NULL
analysis	NULL
on	NULL
cells	NULL
from	NULL
two	NULL
patients	NULL
with	NULL
T-PLL	NULL
carrying	NULL
an	NULL
inversion	NULL
of	NULL
chromosome	NULL
14	NULL
,	NULL
inv	NULL
{	NULL
(	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
.	NULL

Both	NULL
showed	NULL
high	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
,	NULL
comparable	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
the	NULL
SupT11	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
TCL	NULL
Gene	NULL
in	NULL
Tumors	NULL
and	NULL
Normal	NULL
Human	NULL
Tissues	NULL
.	NULL

A	NULL
large	NULL
number	NULL
of	NULL
RNAs	NULL
from	NULL
tumor	NULL
cell	NULL
lines	NULL
,	NULL
both	NULL
of	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
origin	NULL
,	NULL
were	NULL
screened	NULL
to	NULL
study	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
TCLI	NULL
gene	NULL
.	NULL

The	NULL
results	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
reveal	NULL
that	NULL
the	NULL
gene	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
pre-B	NULL
cells	NULL
and	NULL
in	NULL
endemic	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
cell	NULL
surface	NULL
IgM	NULL
and	NULL
do	NULL
not	NULL
secrete	NULL
immunoglobulin	NULL
(	NULL
28	NULL
)	NULL
,	NULL
but	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
sporadic	NULL
Burkitt	NULL
Table	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
TCL1	NULL
mRNA	NULL
in	NULL
cell	NULL
lines	NULL
Cell	NULL
line	NULL
Tumor	NULL
Translocation	NULL
RNA	NULL
RS	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
-	NULL
ALL	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
MV	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
ALL	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
B1	NULL
ALL	NULL
1	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
ALL380	NULL
_	NULL
ALL	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
,	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
+	NULL
ALL-1	NULL
ALL	NULL
1	NULL
(	NULL
9	NULL
;	NULL
22	NULL
)	NULL
+	NULL
BV173	NULL
ALL	NULL
1	NULL
(	NULL
9	NULL
;	NULL
22	NULL
)	NULL
+	NULL
RPMI	NULL
8866	NULL
B-lymphoblastoid	NULL
NA	NULL
GM1500	NULL
_	NULL
B-lymphoblastoid	NULL
Normal	NULL
RPMI	NULL
8226	NULL
Myeloma	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
U226	NULL
Myeloma	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
P3HR-1	NULL
Endemic	NULL
Burkitt	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
+	NULL
AKUA	NULL
Endemic	NULL
Burkitt	NULL
1	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
+	NULL
Daudi	NULL
Endemic	NULL
Burkitt	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
+	NULL
SKDHL	NULL
_	NULL
Sporadic	NULL
Burkitt	NULL
1	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
BL	NULL
2	NULL
Sporadic	NULL
Burkitt	NULL
t	NULL
(	NULL
8	NULL
;	NULL
22	NULL
)	NULL
RS	NULL
High-grade	NULL
B-cell	NULL
11846	NULL
lymphoma	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
,	NULL
t	NULL
(	NULL
8	NULL
;	NULL
22	NULL
)	NULL
+	NULL
K562	NULL
CML	NULL
1	NULL
(	NULL
9	NULL
;	NULL
22	NULL
)	NULL
PEER	NULL
T-ALL	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
Jurkat	NULL
T-ALL	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
MOLT-4	NULL
-	NULL
T-ALL	NULL
t	NULL
(	NULL
7	NULL
;	NULL
7	NULL
)	NULL
,	NULL
6q-	NULL
CEM	NULL
T-ALL	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
Sup	NULL
Tl	NULL
T-ALL	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.3	NULL
)	NULL
SupT1l	NULL
T-ALL	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
+	NULL
HUT	NULL
78	NULL
_	NULL
T-Sezary	NULL
Syndrome	NULL
NA	NULL
HL60	NULL
AML	NULL
Multiple	NULL
rearrangements	NULL
_	NULL
KG-la	NULL
AML	NULL
Multiple	NULL
rearrangements	NULL
_	NULL
U937	NULL
Histiocytic	NULL
lymphoma	NULL
-	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
132	NULL
Retinoblastoma	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
MGC	NULL
Gastric	NULL
carcinoma	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
KATO	NULL
Gastric	NULL
carcinoma	NULL
Multiple	NULL
rearrangements	NULL
_	NULL
SW	NULL
48	NULL
Colorectal	NULL
carcinoma	NULL
_	NULL
Multiple	NULL
rearrangements	NULL
_	NULL
LNCap	NULL
Prostate	NULL
carcinoma	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
PC3	NULL
Prostate	NULL
carcinoma	NULL
Multiple	NULL
rearrangements	NULL
-	NULL
T98G	NULL
Glioblastoma	NULL
Cell	NULL
lines	NULL
with	NULL
multiple	NULL
rearrangements	NULL
do	NULL
not	NULL
have	NULL
translocations	NULL
or	NULL
rearrangements	NULL
at	NULL
14g32.1	NULL
.	NULL

NA	NULL
,	NULL
not	NULL
done	NULL
;	NULL
ALL	NULL
,	NULL
acute	NULL
lymphocytic	NULL
leukemia	NULL
;	NULL
CML	NULL
,	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
;	NULL
T-ALL	NULL
,	NULL
acute	NULL
T-lymphocytic	NULL
leukemia	NULL
;	NULL
AML	NULL
,	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Multiple	NULL
rearrangements	NULL
-	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
-	NULL
12533	NULL
A	NULL
T	NULL
a	NULL
+	NULL
-i	NULL
_J	NULL
A	NULL
o	NULL
&	NULL
o	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5006	NULL
28S	NULL
C	NULL
por	NULL
s	NULL
4a	NULL
soe	NULL
t	NULL
s	NULL
18s	NULL
-	NULL
tel-1	NULL
al	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Expression	NULL
of	NULL
TCLI	NULL
in	NULL
various	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
stimulated	NULL
and	NULL
nonstimulated	NULL
PBLs	NULL
with	NULL
a	NULL
TCLI	NULL
probe	NULL
,	NULL
p697	NULL
;	NULL
11	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
loaded	NULL
per	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
of	NULL
RNA	NULL
from	NULL
T-cell	NULL
lines	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
CEM	NULL
;	NULL
2	NULL
,	NULL
MOLT-4	NULL
;	NULL
3	NULL
,	NULL
HUT	NULL
78	NULL
;	NULL
4	NULL
,	NULL
SupT1	NULL
;	NULL
5	NULL
,	NULL
SupT11	NULL
;	NULL
6	NULL
,	NULL
Jurkat	NULL
.	NULL

(	NULL
C	NULL
)	NULL
RT-PCR	NULL
with	NULL
TCLI	NULL
primers	NULL
,	NULL
p9A	NULL
and	NULL
RevIll	NULL
,	NULL
and	NULL
with	NULL
actin-specific	NULL
primers	NULL
,	NULL
Actinl	NULL
and	NULL
Actin2	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
CEM	NULL
cells	NULL
;	NULL
2	NULL
,	NULL
HUT	NULL
78	NULL
cells	NULL
;	NULL
3	NULL
,	NULL
MOLT-4	NULL
cells	NULL
;	NULL
4	NULL
,	NULL
SupT1	NULL
cells	NULL
;	NULL
5	NULL
,	NULL
SupTi1	NULL
cells	NULL
;	NULL
6	NULL
,	NULL
PBLs	NULL
;	NULL
7	NULL
,	NULL
PHA-activated	NULL
PBLs	NULL
;	NULL
8	NULL
,	NULL
fetal	NULL
thymus	NULL
cells	NULL
.	NULL

lymphomas	NULL
,	NULL
which	NULL
secrete	NULL
immunoglobulin	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
B-lineage	NULL
expression	NULL
is	NULL
illustrated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
TCLZ	NULL
transcripts	NULL
in	NULL
697	NULL
,	NULL
ALL-1	NULL
,	NULL
and	NULL
BV173	NULL
cell	NULL
lines	NULL
,	NULL
all	NULL
with	NULL
a	NULL
pre-B-cell	NULL
phenotype	NULL
,	NULL
and	NULL
by	NULL
its	NULL
absence	NULL
in	NULL
the	NULL
pro-B	NULL
lines	NULL
and	NULL
in	NULL
B-lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
GM1500	NULL
and	NULL
RPMI	NULL
8866	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
TCLI	NULL
gene	NULL
was	NULL
evaluated	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
normal	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Fetal	NULL
bone	NULL
marrow	NULL
B-cell	NULL
subpopulations	NULL
were	NULL
isolated	NULL
by	NULL
flow	NULL
cytometry	NULL
,	NULL
cDNAs	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
PCR	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
primer	NULL
from	NULL
exon	NULL
3	NULL
,	NULL
p9A	NULL
,	NULL
and	NULL
a	NULL
primer	NULL
from	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
,	NULL
RevIlI	NULL
,	NULL
to	NULL
give	NULL
a	NULL
fragment	NULL
of	NULL
270	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

No	NULL
signal	NULL
is	NULL
present	NULL
in	NULL
the	NULL
CD34*CD19~	NULL
stem-cell-rich	NULL
fraction	NULL
;	NULL
weak	NULL
expression	NULL
appears	NULL
in	NULL
the	NULL
CD34*CD19*	NULL
subpopulation	NULL
of	NULL
pro-B	NULL
cells	NULL
,	NULL
and	NULL
expression	NULL
peaks	NULL
in	NULL
IgM-negative	NULL
pre-B	NULL
cells	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
CD19	NULL
.	NULL

TCLLI	NULL
expression	NULL
persists	NULL
in	NULL
immature	NULL
Ig	NULL
M+	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
in	NULL
the	NULL
fetal	NULL
bone	NULL
marrow	NULL
.	NULL

TCL1	NULL
transcripts	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
fetal	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
circulation	NULL
,	NULL
unless	NULL
these	NULL
were	NULL
activated	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

When	NULL
the	NULL
fetal	NULL
thymocytes	NULL
were	NULL
sorted	NULL
into	NULL
subpopulations	NULL
,	NULL
TCLI	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
progenitor	NULL
subpopulation	NULL
of	NULL
CD4-CD8~CD3~	NULL
thymocytes	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
cortical	NULL
population	NULL
(	NULL
CD4*CD8*	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
TCL1	NULL
was	NULL
observed	NULL
in	NULL
myelogenous	NULL
cell	NULL
lines	NULL
or	NULL
in	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
gastric	NULL
(	NULL
MCG	NULL
,	NULL
KATO	NULL
)	NULL
,	NULL
mammary	NULL
(	NULL
MCF7	NULL
)	NULL
,	NULL
prostate	NULL
(	NULL
LNCap	NULL
,	NULL
PC3	NULL
)	NULL
,	NULL
and	NULL
colorectal	NULL
(	NULL
SW48	NULL
)	NULL
carcinomas	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
observed	NULL
in	NULL
polyadenylylated	NULL
RNA	NULL
isolated	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
normal	NULL
human	NULL
tissues	NULL
including	NULL
heart	NULL
,	NULL
brain	NULL
,	NULL
placenta	NULL
,	NULL
lung	NULL
,	NULL
liver	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
pancreas	NULL
(	NULL
data	NULL
not	NULL
1	NULL
``	NULL
2	NULL
a	NULL
.	NULL

4	NULL
5	NULL
tcl-1	NULL
actin	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Expression	NULL
of	NULL
TCLI	NULL
in	NULL
two	NULL
patients	NULL
with	NULL
T-PLL	NULL
.	NULL

RNA	NULL
(	NULL
~5	NULL
ng	NULL
)	NULL
isolated	NULL
from	NULL
patients	NULL
with	NULL
leukemia	NULL
was	NULL
used	NULL
for	NULL
cDNA	NULL
synthesis	NULL
,	NULL
followed	NULL
by	NULL
amplification	NULL
with	NULL
TCLI	NULL
primers	NULL
,	NULL
Daudi	NULL
unil	NULL
and	NULL
Daudi	NULL
rev2	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
Daudi	NULL
;	NULL
2	NULL
,	NULL
SupT11	NULL
;	NULL
3	NULL
,	NULL
patient	NULL
312	NULL
;	NULL
4	NULL
,	NULL
patient	NULL
62	NULL
;	NULL
5	NULL
,	NULL
Jurkat	NULL
.	NULL

12534	NULL
-	NULL
Medical	NULL
Sciences	NULL
:	NULL
Virgilio	NULL
et	NULL
al	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Tol-1	NULL
-	NULL
»	NULL
»	NULL
wam	NULL
mene	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Actin-	NULL
»	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Expression	NULL
of	NULL
TCLI	NULL
in	NULL
isolated	NULL
subpopulation	NULL
of	NULL
bone	NULL
marrow	NULL
B	NULL
cells	NULL
by	NULL
RT-PCR	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
CD34*CDI19~-	NULL
cells	NULL
;	NULL
2	NULL
,	NULL
CD34*CD19+*	NULL
cells	NULL
;	NULL
3	NULL
,	NULL
CD19®m~	NULL
cells	NULL
;	NULL
4	NULL
,	NULL
CD19	NULL
``	NULL
u~	NULL
cells	NULL
;	NULL
5	NULL
,	NULL
CD19+	NULL
'*	NULL
cells	NULL
;	NULL
6	NULL
,	NULL
cells	NULL
.	NULL

shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
TCLI	NULL
is	NULL
constitu-tively	NULL
expressed	NULL
early	NULL
in	NULL
T-	NULL
and	NULL
B-lymphocyte	NULL
differentiation	NULL
within	NULL
their	NULL
respective	NULL
central	NULL
lymphoid	NULL
tissues	NULL
and	NULL
may	NULL
be	NULL
reexpressed	NULL
after	NULL
the	NULL
activation	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
The	NULL
TCLI	NULL
gene	NULL
is	NULL
located	NULL
in	NULL
a	NULL
chromosomal	NULL
region	NULL
banded	NULL
by	NULL
two	NULL
clusters	NULL
of	NULL
breakpoints	NULL
.	NULL

In	NULL
its	NULL
strategic	NULL
position	NULL
,	NULL
between	NULL
the	NULL
two	NULL
clusters	NULL
of	NULL
breakpoints	NULL
,	NULL
the	NULL
TCLI	NULL
gene	NULL
becomes	NULL
juxtaposed	NULL
to	NULL
TCR-Ca/8	NULL
regulatory	NULL
elements	NULL
in	NULL
both	NULL
types	NULL
of	NULL
rearrangements	NULL
involving	NULL
14q32.1	NULL
.	NULL

For	NULL
inversions	NULL
,	NULL
the	NULL
TCLLI	NULL
gene	NULL
is	NULL
telomeric	NULL
to	NULL
the	NULL
14q32.1	NULL
break	NULL
;	NULL
hence	NULL
,	NULL
the	NULL
central	NULL
part	NULL
of	NULL
the	NULL
chromosome	NULL
between	NULL
q11	NULL
and	NULL
q32	NULL
has	NULL
flipped	NULL
upside	NULL
down	NULL
and	NULL
Ca/8	NULL
has	NULL
been	NULL
positioned	NULL
centromeric	NULL
and	NULL
in	NULL
proximity	NULL
to	NULL
the	NULL
TCLI	NULL
gene	NULL
;	NULL
the	NULL
same	NULL
holds	NULL
true	NULL
for	NULL
translocations	NULL
with	NULL
inverted	NULL
duplication	NULL
.	NULL

For	NULL
simple	NULL
translocations	NULL
,	NULL
the	NULL
gene	NULL
is	NULL
centromeric	NULL
to	NULL
the	NULL
breaks	NULL
and	NULL
does	NULL
not	NULL
move	NULL
during	NULL
the	NULL
rearrangement	NULL
.	NULL

In	NULL
this	NULL
case	NULL
the	NULL
break	NULL
on	NULL
the	NULL
other	NULL
chromosome	NULL
14	NULL
occurs	NULL
in	NULL
TCR	NULL
a/8	NULL
locus	NULL
that	NULL
moves	NULL
to	NULL
a	NULL
region	NULL
telomeric	NULL
to	NULL
the	NULL
TCLI	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
model	NULL
of	NULL
activation	NULL
the	NULL
TCL	NULL
I	NULL
gene	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
control	NULL
elements	NULL
of	NULL
the	NULL
TCR	NULL
gene	NULL
,	NULL
whether	NULL
they	NULL
are	NULL
positioned	NULL
5	NULL
'	NULL
of	NULL
the	NULL
TCL	NULL
]	NULL
gene	NULL
,	NULL
as	NULL
for	NULL
translocations	NULL
,	NULL
or	NULL
3	NULL
'	NULL
to	NULL
TCL1	NULL
,	NULL
as	NULL
for	NULL
inversions	NULL
.	NULL

A	NULL
similar	NULL
situation	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
Burkitt	NULL
lymphomas	NULL
,	NULL
where	NULL
the	NULL
immunoglobulin	NULL
enhancers	NULL
can	NULL
be	NULL
located	NULL
upstream	NULL
or	NULL
downstream	NULL
to	NULL
the	NULL
MYC	NULL
oncogene	NULL
(	NULL
16	NULL
,	NULL
18	NULL
,	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
immunoglobulin	NULL
enhancers	NULL
are	NULL
found	NULL
downstream	NULL
to	NULL
the	NULL
BCL2	NULL
gene	NULL
in	NULL
follicular	NULL
lymphomas	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
and	NULL
upstream	NULL
to	NULL
the	NULL
BCL2	NULL
gene	NULL
in	NULL
B-cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
study	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
indicates	NULL
that	NULL
it	NULL
is	NULL
expressed	NULL
preferentially	NULL
in	NULL
cells	NULL
of	NULL
lymphoid	NULL
lineage	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
TCL	NULL
I	NULL
begins	NULL
in	NULL
normal	NULL
B-lineage	NULL
cells	NULL
as	NULL
early	NULL
as	NULL
the	NULL
CD34*CDI19*	NULL
pro-B-cell	NULL
stage	NULL
.	NULL

Its	NULL
expression	NULL
peaks	NULL
in	NULL
pre-B	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
CD19	NULL
but	NULL
no	NULL
cell	NULL
surface	NULL
IgM	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
persists	NULL
in	NULL
immature	NULL
Ig	NULL
M*	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mature	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
periphery	NULL
do	NULL
not	NULL
express	NULL
TCL1	NULL
.	NULL

These	NULL
findings	NULL
parallel	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
lymphoid	NULL
cell	NULL
lines	NULL
where	NULL
pro-B-cell	NULL
lines	NULL
with	NULL
the	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
chromosome	NULL
translocation	NULL
failed	NULL
to	NULL
express	NULL
TCLI	NULL
,	NULL
while	NULL
pre-B-cell	NULL
lines	NULL
expressed	NULL
TCL/	NULL
transcripts	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
TCL1I	NULL
expression	NULL
is	NULL
noted	NULL
for	NULL
early	NULL
T-lineage	NULL
cells	NULL
.	NULL

Immature	NULL
thymocytes	NULL
,	NULL
including	NULL
the	NULL
intermediate	NULL
CD4*/	NULL
CD8	NULL
+	NULL
population	NULL
,	NULL
express	NULL
TCLI	NULL
transcripts	NULL
,	NULL
whereas	NULL
mature	NULL
T	NULL
cells	NULL
in	NULL
circulation	NULL
do	NULL
not	NULL
,	NULL
unless	NULL
they	NULL
are	NULL
activated	NULL
,	NULL
when	NULL
TCL1	NULL
transcripts	NULL
may	NULL
be	NULL
expressed	NULL
in	NULL
relatively	NULL
low	NULL
levels	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
TCL	NULL
]	NULL
gene	NULL
may	NULL
be	NULL
linked	NULL
to	NULL
immunoglobulin	NULL
and	NULL
TCR	NULL
gene	NULL
rearrangement	NULL
and	NULL
expression	NULL
.	NULL

The	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
TCL	NULL
]	NULL
in	NULL
leukemic	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
and	NULL
the	NULL
inv	NULL
(	NULL
{	NULL
(	NULL
14	NULL
)	NULL
inver-sion	NULL
,	NULL
but	NULL
not	NULL
in	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
with	NULL
other	NULL
types	NULL
of	NULL
chromosomal	NULL
rearrangements	NULL
,	NULL
strongly	NULL
supports	NULL
the	NULL
conclusion	NULL
that	NULL
this	NULL
gene	NULL
becomes	NULL
deregulated	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
its	NULL
juxtaposition	NULL
to	NULL
the	NULL
a/8	NULL
TCR	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
We	NULL
thank	NULL
K.	NULL
Gripp	NULL
for	NULL
providing	NULL
patient	NULL
samples	NULL
,	NULL
A.	NULL
ar-Rushdi	NULL
and	NULL
T.	NULL
Nakamura	NULL
for	NULL
contributing	NULL
cDNA	NULL
libraries	NULL
,	NULL
D.	NULL
Rasio	NULL
for	NULL
technical	NULL
support	NULL
,	NULL
and	NULL
S.	NULL
Smith	NULL
for	NULL
providing	NULL
the	NULL
cell	NULL
line	NULL
Supt11	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
H.	NULL
Alder	NULL
for	NULL
automated	NULL
DNA	NULL
sequencing	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
K.	NULL
Huebner	NULL
and	NULL
P.	NULL
Burrows	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manu-script	NULL
.	NULL

This	NULL
work	NULL
was	NULL
partially	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA39860	NULL
to	NULL
C.M.C	NULL
.	NULL

M.D.C.	NULL
is	NULL
a	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
Investigator	NULL
and	NULL
L.G.B	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Cancer	NULL
Research	NULL
Institute	NULL
.	NULL

1	NULL
.	NULL

Haluska	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Tsujimoto	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Genet	NULL
.	NULL

21	NULL
,	NULL
321-345	NULL
.	NULL

2	NULL
.	NULL

Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
155-156	NULL
.	NULL

3	NULL
.	NULL

Croce	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Palumbo	NULL
,	NULL
A.	NULL
,	NULL
Puck	NULL
,	NULL
J.	NULL
,	NULL
Erikson	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Rovera	NULL
,	NULL
G.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
227	NULL
,	NULL
1044-1047	NULL
.	NULL

4	NULL
.	NULL

Isobe	NULL
,	NULL
M.	NULL
,	NULL
Russo	NULL
,	NULL
G.	NULL
,	NULL
Haluska	NULL
,	NULL
F.	NULL
G.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
3933-3937	NULL
.	NULL

5	NULL
.	NULL

Brito-Babapulle	NULL
,	NULL
V.	NULL
&	NULL
Catovsky	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

55	NULL
,	NULL
1-9	NULL
.	NULL

6	NULL
.	NULL

Russo	NULL
,	NULL
G.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
Finan	NULL
,	NULL
J.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
137-144	NULL
.	NULL

7	NULL
.	NULL

Russo	NULL
,	NULL
G.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Gatti	NULL
,	NULL
R.	NULL
,	NULL
Finan	NULL
,	NULL
J.	NULL
,	NULL
Botuman	NULL
,	NULL
O.	NULL
,	NULL
Huebner	NULL
,	NULL
K.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
602-606	NULL
.	NULL

8	NULL
.	NULL

Baer	NULL
,	NULL
R.	NULL
,	NULL
Heppel	NULL
,	NULL
A.	NULL
,	NULL
Taylor	NULL
,	NULL
A.	NULL
M.	NULL
R.	NULL
,	NULL
Rabbits	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Boullier	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
9069-9073	NULL
.	NULL

9	NULL
.	NULL

Mengle-Gaw	NULL
,	NULL
L.	NULL
,	NULL
Willard	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
I.	NULL
E.	NULL
,	NULL
Hammerstrom	NULL
,	NULL
L.	NULL
,	NULL
Fisher	NULL
,	NULL
P.	NULL
,	NULL
Sherrington	NULL
,	NULL
P.	NULL
,	NULL
Lucas	NULL
,	NULL
G.	NULL
,	NULL
Thompson	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Baer	NULL
,	NULL
R.	NULL
&	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2273-2280	NULL
.	NULL

10	NULL
.	NULL

Bertness	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Felix	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
McBride	NULL
,	NULL
W.	NULL
O.	NULL
,	NULL
Morgan	NULL
,	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Sandberg	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Kirsh	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

44	NULL
,	NULL
47-54	NULL
.	NULL

11	NULL
.	NULL

Virgilio	NULL
,	NULL
L.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Narducci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Carotenuto	NULL
,	NULL
P.	NULL
,	NULL
Camerini	NULL
,	NULL
B.	NULL
,	NULL
Kuroswa	NULL
,	NULL
N.	NULL
,	NULL
ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Russo	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
9275-9279	NULL
.	NULL

12	NULL
.	NULL

Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
Yunis	NULL
,	NULL
J.	NULL
,	NULL
Onorato-Showe	NULL
,	NULL
L.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Science	NULL
224	NULL
,	NULL
1403-1406	NULL
.	NULL

13	NULL
.	NULL

Rosenberg	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Wong	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Petty	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Bale	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
Harris	NULL
,	NULL
N.	NULL
L.	NULL
&	NULL
Amold	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
9638-9642	NULL
.	NULL

14	NULL
.	NULL

Whither	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Harvey	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Faust	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Melney	NULL
,	NULL
K.	NULL
O.	NULL
,	NULL
Carey	NULL
,	NULL
K.	NULL
&	NULL
Meeker	NULL
,	NULL
T.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4846-4853	NULL
.	NULL

15	NULL
.	NULL

Motokura	NULL
,	NULL
T.	NULL
&	NULL
Arnold	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Chromosomes	NULL
Cancer	NULL
7	NULL
,	NULL
89-95	NULL
.	NULL

16	NULL
.	NULL

Dalla-Favera	NULL
,	NULL
R.	NULL
,	NULL
Bregni	NULL
,	NULL
M.	NULL
,	NULL
Erikson	NULL
,	NULL
J.	NULL
,	NULL
Patterson	NULL
,	NULL
D.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79	NULL
,	NULL
7824-7827	NULL
.	NULL

17	NULL
.	NULL

-	NULL
Nishikura	NULL
,	NULL
K.	NULL
,	NULL
ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Erikson	NULL
,	NULL
J.	NULL
,	NULL
Watt	NULL
,	NULL
R.	NULL
,	NULL
Rovera	NULL
,	NULL
G.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
4822-4826	NULL
.	NULL

18	NULL
.	NULL

-	NULL
Erikson	NULL
,	NULL
J.	NULL
,	NULL
Sun	NULL
,	NULL
L.	NULL
,	NULL
ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Nishikura	NULL
,	NULL
K.	NULL
,	NULL
Minowada	NULL
,	NULL
J.	NULL
,	NULL
Finan	NULL
,	NULL
J.	NULL
,	NULL
Emanuel	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
884-886	NULL
.	NULL

19	NULL
.	NULL

Davis	NULL
,	NULL
L.	NULL
G.	NULL
,	NULL
Dibner	NULL
,	NULL
M.	NULL
D.	NULL
&	NULL
Battey	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
Basic	NULL
Methods	NULL
in	NULL
Molecular	NULL
Biology	NULL
(	NULL
Elsevier	NULL
,	NULL
New	NULL
York	NULL
)	NULL
.	NULL

20	NULL
.	NULL

-	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

21	NULL
.	NULL

Hamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Sakamoto	NULL
,	NULL
H.	NULL
,	NULL
Tsurata	NULL
,	NULL
H.	NULL
,	NULL
Sasaki	NULL
,	NULL
H.	NULL
,	NULL
Muto	NULL
,	NULL
T.	NULL
,	NULL
Sugimura	NULL
,	NULL
T.	NULL
&	NULL
Terada	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
9779-9783	NULL
.	NULL

22	NULL
.	NULL

Buckler	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Chang	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Graw	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Brook	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Haber	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Housman	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
4005-4009	NULL
.	NULL

23	NULL
.	NULL

Nishimoto	NULL
,	NULL
N.	NULL
,	NULL
Kubagwa	NULL
,	NULL
H.	NULL
,	NULL
Ohno	NULL
,	NULL
T.	NULL
,	NULL
Gartland	NULL
,	NULL
Stankovic	NULL
,	NULL
A.	NULL
K.	NULL
&	NULL
Cooper	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
6284-6289	NULL
.	NULL

24	NULL
.	NULL

-	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
McFall	NULL
,	NULL
P.	NULL
,	NULL
Morgan	NULL
,	NULL
R.	NULL
,	NULL
Link	NULL
,	NULL
M.	NULL
,	NULL
Hecht	NULL
,	NULL
F.	NULL
,	NULL
Cleary	NULL
,	NULL
M.	NULL
&	NULL
Sklar	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
73	NULL
,	NULL
2182-2187	NULL
.	NULL

25	NULL
.	NULL

Lindsay	NULL
,	NULL
S.	NULL
&	NULL
Bird	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
327	NULL
,	NULL
336-338	NULL
.	NULL

26	NULL
.	NULL

Baer	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
&	NULL
Rabbits	NULL
,	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
43	NULL
,	NULL
705-713	NULL
.	NULL

27	NULL
.	NULL

Ellisen	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
Bird	NULL
,	NULL
J.	NULL
,	NULL
West	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Sareng	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Reynolds	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
&	NULL
Sklar	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
649-661	NULL
.	NULL

28	NULL
.	NULL

Magrath	NULL
,	NULL
I.	NULL
T.	NULL
,	NULL
Freeman	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Pizzo	NULL
,	NULL
P.	NULL
,	NULL
Gadek	NULL
,	NULL
J.	NULL
,	NULL
Jaffe	NULL
,	NULL
E.	NULL
,	NULL
Santaella	NULL
,	NULL
M.	NULL
,	NULL
Hammer	NULL
,	NULL
C.	NULL
,	NULL
Frank	NULL
,	NULL
M.	NULL
,	NULL
Reaman	NULL
,	NULL
G.	NULL
&	NULL
Novikovs	NULL
,	NULL
L.	NULL
(	NULL
1980	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

64	NULL
,	NULL
477-483	NULL
.	NULL

29	NULL
.	NULL

Croce	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
,	NULL
Erikson	NULL
,	NULL
J.	NULL
,	NULL
Nishikura	NULL
,	NULL
K.	NULL
,	NULL
Finan	NULL
,	NULL
J.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
&	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
6922-6926	NULL
.	NULL

30	NULL
.	NULL

Erikson	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Nishikura	NULL
,	NULL
K.	NULL
,	NULL
ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Finan	NULL
,	NULL
J.	NULL
,	NULL
Emanuel	NULL
,	NULL
B.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
7581-7585	NULL
.	NULL

31	NULL
.	NULL

Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
Cossman	NULL
,	NULL
J.	NULL
,	NULL
Jaffe	NULL
,	NULL
E.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
1440-1443	NULL
.	NULL

32	NULL
.	NULL

Tsujimoto	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
5214-5218	NULL
.	NULL

33	NULL
.	NULL

Adachi	NULL
,	NULL
M.	NULL
,	NULL
Cossman	NULL
,	NULL
J.	NULL
,	NULL
Longo	NULL
,	NULL
D.	NULL
,	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Tsujimoto	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2771-2774	NULL
.	NULL

